It is now well accepted that dysfunctional metabolism is associated with many different disease states, including cancer, immunological disorders, neurodegeneration, diabetes, and obesity. Therefore, looking at the genes, proteins, and pathways that modulate metabolism is a promising avenue for developing novel therapeutic targets for a broad range of diseases.
Agilent Seahorse XF technology measures energy metabolism in live cells, providing critical information that relates directly to cellular function.
Download this application note to discover how the Seahorse XF assay can be used to predict:
Technology Networks Limited
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK
Email: privacy@technologynetworks.com
© 2019 Technology Networks. All rights reserved
Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy